Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non–Small-cell Lung Cancer Patients
- Resource Type
- Article
- Source
- In
Clinical Lung Cancer May 2018 19(3):e361-e372 - Subject
- Language
- ISSN
- 1525-7304